TORREY COPE advises clients on FDA regulatory issues. He is an experienced regulatory lawyer with scientific training and a passion for helping pharmaceutical, biotechnology and medical technology companies solve their most challenging regulatory problems, whether they involve clinical trials, marketing authorization, promotion, product safety or other issues. His clients include companies at the forefront of innovation, who are developing novel products in emerging technological fields such as immunotherapy, regenerative medicine, genetic testing/next generation sequencing (NGS) and digital health.
Torrey was included in The Best Lawyers in America 2018 for FDA Law, was named a “Rising Star” for Life Sciences in LMG’s 2017 and 2018 Expert Guides, and has been recognized for FDA (Pharmaceutical) work by LMG Life Sciences since 2016. His work involves counseling clients on regulatory issues and representing clients in the full range of non-regulatory matters in which FDA issues arise. For example, he regularly helps clients develop approval and marketing strategies, identify and mitigate regulatory risk associated with strategic initiatives, and develop FDA-based defenses to healthcare enforcement investigations. He also handles challenges to competitor advertising before the National Advertising Division (NAD) and serves as FDA counsel in product liability cases, civil litigation and FDA enforcement proceedings. In addition, he regularly works hand-in-hand with colleagues in Sidley’s Emerging Companies and Venture Capital, Private Equity, Securities, M&A and Technology and IP Transactions groups to provide clients with integrated, strategically-oriented regulatory advice on a wide variety of life sciences transactions.
Before law school, Torrey conducted research in molecular biology, then was a quality control microbiologist for a major sterile drug manufacturer.